Rigel Pharmaceuticals INC
SEC CIK 1034842 · RIGL · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Ali-Jackson Kamil | Director | filed 2021 - 2026 |
| Rodriguez Raul R | Director · President & COO | filed 2006 - 2026 |
| Moos Walter H | Director | filed 2006 - 2026 |
| Miller Michael Patrick | Director | filed 2026 - 2026 |
| Lapointe Gregg Anthony | Director | filed 2017 - 2026 |
| Wasman Jane | Director | filed 2019 - 2026 |
| Frohlich Mark W | Director | filed 2025 - 2026 |
| Hannah Alison L. | Director | filed 2021 - 2026 |
| Kotzin Brian L. | Director | filed 2017 - 2024 |
| Lyons Gary A | Director | filed 2006 - 2023 |
| Goodwin Bradford S | Director | filed 2007 - 2021 |
| Katkin Keith | Director | filed 2015 - 2021 |
| Ringrose Peter S | Director | filed 2006 - 2018 |
| Payan Donald G | Director · Ex. VP Chief Sci. Officer | filed 2006 - 2016 |
| Sherwin Stephen A | Director | filed 2006 - 2016 |
| Gower James M | Director · CEO & Board Chairman | filed 2006 - 2014 |
| Renton Hollings | Director | filed 2006 - 2013 |
| Deleage Jean | Director | filed 2006 - 2010 |
| Frazier Alan D | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Schorno Dean L | EVP &Chief Financial Officer | filed 2018 - 2026 |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec | filed 2022 - 2026 |
| Santos David A | EVP, Chief Commercial Officer | filed 2020 - 2026 |
| Rojkjaer Lisa | EVP, Chief Medical Officer | filed 2024 - 2026 |
| Dummer Wolfgang | EVP & CMO | filed 2019 - 2023 |
| Vance Dolly | VP Intel. Prop.& Gen.Counsel | filed 2006 - 2022 |
| Cabatuan Nelson | VP,Finance & Princ.Acctg. Off. | filed 2017 - 2020 |
| Masuda Esteban | Sr. VP Research | filed 2016 - 2019 |
| Lasaga Joseph | VP Bus. Dev.& Alliance Mgmt. | filed 2016 - 2019 |
| Mayer Eldon C. III | EVP &Chief Commercial Officer | filed 2016 - 2019 |
| Duliege Anne-Marie | EVP & Chief Medical Officer | filed 2016 - 2019 |
| Markel Stacy | EVP Human Resources | filed 2018 - 2019 |
| Maynard Ryan D | VP, CFO | filed 2006 - 2017 |
| Grossbard Elliott B | Sr. VP Medical Development | filed 2006 - 2016 |
| Cooper Robin D G | Sr. V.P. Pharmaceutical Scs. | filed 2006 - 2008 |
| Welch James H | CFO, VP & Secretary | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.